New Platform Targets and Represses Disease-Causing Genes
Read about Ornit Chiba-Falek, PhD's collaboration to develop a new platform that targets specific genes that can cause disease.
How Neurologists Are Integrating APPs Into Practice
Dr. Morgenlander discusses how advanced practice providers have become increasingly important to expanding access to neurology services.
Bedlack Recipient of Inaugural Accelerate a Miracle Project Award
Richard Bedlack, MD, PhD has been named as the inaugural recipient of the Accelerate a Miracle Project (or AMP) Award by the Hop on a Cure Foundation.
83-Year-Old Duke Scientist's Brain Cancer Research Helps Drug get FDA Approval
Dr. Peters discusses the clinical trial outcomes using the drug Voranigo to treat low-grade brain cancer.
Johnson named Duke Centennial Trailblazer
Kim G. Johnson, MD has been named a Duke Centennial Trailblazer for her work with Alzheimer's.
Study Finds Genetic Variant Among People Who Experience a Rare Recovery from ALS
Read more about a study co-lead by Dr. Bedlack regarding ALS recovery.
Finally, Some Good News About Alzheimer's
Dr. Whitson discusses advances in Alzheimer’s prevention, detection, and treatment success.
9 Medications You Should Avoid Taking Before Going To Sleep
Dr. Spector provides insight into medications that can impact sleep.
These Vertigo Exercises Stop Dizziness in Minutes, and the Results Can Last a Year or More
Dr. Beaty discusses exercises that help with vertigo.
Mixed Topline Data Reported in Phase 3 RAISE Trial of Ganaxolone for Refractory Status Epilepticus
Dr. Husain provides perspective on the failure of the ganaxolone treatment trial for persistent seizures.